We identified the breast cancer gene BRCA2, which enabled families with a history of breast cancer to be assessed for future risk, and laid the groundwork for developing novel forms of therapy for ...

We played a leading role in clinical trials that demonstrated the effectiveness of aromatase inhibitors in breast cancer, and in identifying and validating biomarkers to determine who could benefit ...

The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...

The ICR provides a free 24 hour counselling service for all staff and students and family members of their household. The service also includes a consumer and legal helpline. The National Union of ...

We have made huge strides in research and treatment for children with cancer, improving their chances of survival. With your support today, we can discover kinder treatments and offer more children ...

The Institute of Cancer Research is committed to the professional development of its staff. In addition to the training and support provided within individual teams, the Learning and Development Team ...

The Centre for Cancer Drug Discovery at The Institute of Cancer Research, London, is the largest academic cancer drug discovery and development group worldwide. Its research groups cover every aspect ...

We transformed care for advanced prostate cancer, by validating inhibitors of androgen production as an effective cancer treatment, and discovering and developing abiraterone, a life-extending ...

The Division of Cancer Biology is focused on understanding the molecular alterations important in the development and progression of cancer, and in determining how the disease responds to treatment.

The Institute of Cancer Research believes that animal research is essential to understand how cancers develop and behave within a whole organism, and how to treat it effectively. We use animal studies ...